JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1826
PUT
Cigna
CI
$70.8B
| $13.4M | ﹤0.01% |
65,800
+10,000
| +18% | +$1.99M |
2017 Q3
1 quarter
|
|
1827
OFG Bancorp
OFG
$2.14B
| $13.4M | ﹤0.01% |
1,420,798
+27,836
| +2% | +$250K |
2013 Q2
18 quarters
|
|
1828
Vanguard Morningstar Value ETF
VTV
$185B
| $13.4M | ﹤0.01% |
125,621
+15,477
| +14% | +$1.6M |
2013 Q2
18 quarters
|
|
1829
Steris
STE
$20.4B
| $13.3M | ﹤0.01% |
152,455
+84,836
| +125% | +$7.57M |
2014 Q4
12 quarters
|
|
1830
Enerpac Tool Group
EPAC
$1.79B
| $13.3M | ﹤0.01% |
526,675
+244,421
| +87% | +$6.3M |
2015 Q4
8 quarters
|
|
1831
Boston Beer
SAM
$1.71B
| $13.3M | ﹤0.01% |
69,694
-48,557
| -41% | -$8.67M |
2014 Q3
13 quarters
|
|
|
FL
1832
DELISTED
Foot Locker
FL
| $13.3M | ﹤0.01% |
283,490
-493,919
| -64% | -$18.4M |
2013 Q2
18 quarters
|
|
1833
Kite Realty
KRG
$4.9B
| $13.3M | ﹤0.01% |
677,141
+60,525
| +10% | +$1.18M |
2013 Q2
18 quarters
|
|
1834
Sensient Technologies
SXT
$5.47B
| $13.2M | ﹤0.01% |
180,495
+130,517
| +261% | +$9.95M |
2013 Q2
18 quarters
|
|
|
FMBI
1835
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $13.2M | ﹤0.01% |
549,895
+156,681
| +40% | +$3.72M |
2013 Q2
18 quarters
|
|
|
AAMI
1836
Acadian Asset Management
AAMI
$3.34B
| $13.2M | ﹤0.01% |
786,957
+29,206
| +4% | +$464K |
2016 Q4
4 quarters
|
|
1837
Genpact
G
$5.83B
| $13.1M | ﹤0.01% |
414,001
+104,682
| +34% | +$3.24M |
2013 Q2
18 quarters
|
|
1838
Nelnet
NNI
$4.42B
| $13.1M | ﹤0.01% |
239,879
-4,021
| -2% | -$217K |
2013 Q2
18 quarters
|
|
1839
PUT
Royal Gold
RGLD
$19.7B
| $13.1M | ﹤0.01% |
160,000
+100,000
| +167% | +$8.57M |
2015 Q4
8 quarters
|
|
1840
PUT
Ford
F
$48.9B
| $13.1M | ﹤0.01% |
1,050,900
+456,300
| +77% | +$5.62M |
2015 Q3
9 quarters
|
|
1841
Plexus
PLXS
$7.2B
| $13.1M | ﹤0.01% |
215,645
+9,919
| +5% | +$601K |
2015 Q3
9 quarters
|
|
1842
Helmerich & Payne
HP
$3.82B
| $13.1M | ﹤0.01% |
202,031
-52,302
| -21% | -$2.93M |
2013 Q2
18 quarters
|
|
1843
British American Tobacco
BTI
$114B
| $13M | ﹤0.01% |
194,791
-750,274
| -79% | -$48.9M |
2013 Q2
18 quarters
|
|
1844
Stride
LRN
$3.22B
| $13M | ﹤0.01% |
820,527
-21,103
| -3% | -$351K |
2014 Q2
14 quarters
|
|
|
LXFT
1845
DELISTED
Luxoft Holding, Inc.
LXFT
| $13M | ﹤0.01% |
233,672
-652,037
| -74% | -$32.7M |
2013 Q4
16 quarters
|
|
|
GXP
1846
DELISTED
Great Plains Energy Incorporated
GXP
| $13M | ﹤0.01% |
402,422
-638,908
| -61% | -$21M |
2013 Q2
18 quarters
|
|
|
SCG
1847
DELISTED
Scana
SCG
| $13M | ﹤0.01% |
325,614
+171,875
| +112% | +$7.68M |
2013 Q2
18 quarters
|
|
|
1848
CALL
Ford
F
$48.9B
| $12.9M | ﹤0.01% |
1,036,500
+567,200
| +121% | +$6.98M |
2015 Q3
9 quarters
|
|
1849
PUT
IBM
IBM
$213B
| $12.9M | ﹤0.01% |
88,178
+52,509
| +147% | +$7.64M |
2015 Q3
9 quarters
|
|
|
EVF
1850
Eaton Vance Senior Income Trust
EVF
$87.9M
| $12.9M | ﹤0.01% |
1,980,980
+18,033
| +0.9% | +$117K |
2014 Q3
13 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.